GlassScriptPhysician profile
Terry John Braud
NPI 1508076456
$596.82
in general payments reported to CMS, 2019-2025
8 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $106 · 2023: $206 · 2024: $119 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $490.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $159.17 | 2023-2025 | General - Pain Management |
| Valinor Pharma, LLC | $150.82 | 2023-2024 | Movantik |
| Tactile Systems Technology INC | $106.26 | 2022 | |
| Abbott Laboratories | $71.03 | 2025 | Eterna, Proclaim |
| Ibsa Pharma INC. | $55.91 | 2023-2024 | Tirosint, Licart, Tirosint |
| Eagle Pharmaceuticals, INC. | $18.99 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $17.44 | 2023 | Zilretta, Iovera |
| Spinal Simplicity, LLC | $17.20 | 2023 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Braud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.